RDUS - Radius Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.25B
Enterprise Value 3
1.27B
Trailing P/E
N/A
Forward P/E 1
-10.09
PEG Ratio (5 yr expected) 1
-0.28
Price/Sales (ttm)
9.41
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
9.53
Enterprise Value/EBITDA 6
-8.62

Trading Information

Stock Price History

Beta (3Y Monthly) 0.83
52-Week Change 347.65%
S&P500 52-Week Change 39.71%
52 Week High 329.97
52 Week Low 312.81
50-Day Moving Average 326.79
200-Day Moving Average 323.49

Share Statistics

Avg Vol (3 month) 3567.07k
Avg Vol (10 day) 3635.6k
Shares Outstanding 546.12M
Float 43.58M
% Held by Insiders 10.95%
% Held by Institutions 1109.13%
Shares Short (Sep 30, 2019) 46.6M
Short Ratio (Sep 30, 2019) 48.93
Short % of Float (Sep 30, 2019) 416.82%
Short % of Shares Outstanding (Sep 30, 2019) 414.31%
Shares Short (prior month Aug 30, 2019) 46.88M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Apr 24, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -127.22%
Operating Margin (ttm)-112.57%

Management Effectiveness

Return on Assets (ttm)-31.10%
Return on Equity (ttm)-247.59%

Income Statement

Revenue (ttm)132.95M
Revenue Per Share (ttm)2.91
Quarterly Revenue Growth (yoy)81.40%
Gross Profit (ttm)91.61M
EBITDA -146.91M
Net Income Avi to Common (ttm)-169.13M
Diluted EPS (ttm)-3.70
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)188.48M
Total Cash Per Share (mrq)4.09
Total Debt (mrq)194.58M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.38
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-136.82M
Levered Free Cash Flow (ttm)-76.7M